Ertugliflozin in Chronic Heart Failure: Cardio-renal and Diuretic Effects
Latest Information Update: 10 Mar 2025
At a glance
- Drugs Ertugliflozin (Primary) ; Metolazone
- Indications Chronic heart failure
- Focus Therapeutic Use
Most Recent Events
- 07 Mar 2025 Planned primary completion date changed from 31 Jan 2025 to 30 Jun 2025.
- 21 Dec 2023 Planned number of patients changed from 90 to 60.
- 19 Dec 2023 Planned End Date changed from 1 Jul 2024 to 1 Jul 2025.